Whitney's blog

ALBUQUERQUE – April 15, 2024 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) today announced the completion of New Mexico’s first FARAPULSE ™ Pulsed Field Ablation, a new alternative to standard-of-care thermal ablation, for the treatment of atrial fibrillation (AFib). A non-thermal approach for the treatment of intermittent AFib, it is proven to be an effective treatment option for patients while minimizing risks associated with thermal ablation.

ALBUQUERQUE – April 5, 2024 –Lovelace Medical Center (LMC) completed its first right robotic pleural biopsy. The minimally invasive thoracic procedure was performed by Luis Cerda, M.D., cardiothoracic surgeon with the New Mexico Heart Institute/Lovelace Medical Group, using Intuitive’s Da Vinci Xi robotic system, which makes smaller incisions than the traditional open procedure, resulting in less postoperative pain, reduced infection risk and quicker recovery and hospital stay.

ALBUQUERQUE – January 8, 2024 – New Mexico Heart Institute/Lovelace Medical Group (NMHI) has enrolled the first patient in the world in the RECOVER IV randomized study comparing management strategies for patients with cardiogenic shock using the Impella CP®, an FDA-approved temporary heart pump, versus standard of care.

Troy Greer returns to Lovelace as David Schultz assumes enterprise leadership role

ROSWELL, November 7, 2023 — Lovelace Regional Hospital (LRH) received an “A” safety grade in the Fall 2023 Leapfrog Hospital Safety Grade report, a national distinction recognizing its achievements protecting patients from harm and error in the hospital. This is the sixth safety grade “A” in a row for LRH.

ALBUQUERQUE – November 2, 2023 – Lovelace Health System (LHS) today announced the appointments of Brian Miller, BSIE, MSE, as the chief executive officer (CEO) of Lovelace Medical Center (LMC) and administrator of the Heart Hospital of New Mexico (HHNM) and Michael Kueker, MBA, as CEO of Lovelace Medical Group (LMG).

ALBUQUERQUE – October 18, 2023 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) has received credentialing from DNV as a Ventricular Assist Device (VAD) Facility, demonstrating the hospital’s readiness to provide the full spectrum of VAD Program services – diagnosis, treatment, rehabilitation, and patient and community education – as well as clear metrics to evaluate program outcomes.

ALBUQUERQUE – October 17, 2023 – Lovelace Health System (LHS) was awarded the American Nursing Credentialing Center (ANCC) Practice Transition Accreditation Program (PTAP), signifying that the hospital is following best practices and utilizing an evidence-based curriculum that is focused on helping the new graduate nurse transition from student nurse into professional nursing practice. LHS is one of only 249 programs in the world who have received this accreditation.

ALBUQUERQUE – October 9, 2023 – Lovelace Westside Hospital (LWSH) received accreditation under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint quality program of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS), demonstrating its commitment to ensuring the safe and effective performance of metabolic and bariatric surgery.

ALBUQUERQUE, October 6, 2023 ––Lovelace UNM Rehabilitation Hospital (LURH) was given the Top Hospital Quality award for Quest for Excellence, the New Mexico Hospital Association’s (NMHA’s) premier honor for exceptional efforts to advance quality and patient care for the people of New Mexico. LURH was also named the winner in the Specialty Hospital category for its project, “Mitigating Medication Error: How Going to Gemba Saved a Critical Process.”